The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.
Del Poeta G, Del Principe MI, Consalvo MA, Maurillo L, Buccisano F, Venditti A, Mazzone C, Bruno A, Gianní L, Capelli G, Lo Coco F, Cantonetti M, Gattei V, Amadori S.
Del Poeta G, et al. Among authors: capelli g.
Cancer. 2005 Dec 15;104(12):2743-52. doi: 10.1002/cncr.21535.
Cancer. 2005.
PMID: 16284990
Free article.
Clinical Trial.